On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...

Several hours later, she woke up from a deep sleep feeling sick to her stomach. She vomited and had diarrhea. She asked her ...

Several workers at Upstate Correctional Facility in Franklin County were transported to a hospital late Saturday following a ...

Biohaven wielded meals at high-end restaurants and paid speaking opportunities to induce healthcare providers to prescribe ...

Machine Gun Among 2 Loaded Firearms Found On Men In Stolen Car: Fairfax County PD 'Wawa Has Disgusting Pizza:' Portnoy Pitches Ad Idea Outside Gas Station Nasal Spray Treating Major Depression ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

PDUFA date of March 27, 2025 for CARDAMYST (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT targe ...

"One aspect that's often overlooked is the role of medications. Blood thinners, such as aspirin or anticoagulants, can ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...